Detail

Study ID: Alliance A041701

Title:

A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

Location:
Bismarck Region, Fargo Region, Sioux Falls Region
Principal Investigator:
Preston Steen, MD,Preston Steen, MD,Preston Steen, MD
Disease:
AML (Acute Myelogenic Leukemia)
Stage:
Phase II/III
Status:
Active - Open to Accrual